IP Library Granted Patent US 12,201,713
Granted Patent B2
US 12,201,713 · App. 17/901,710 · Granted Jan 21, 2025

Personal care compositions

Inventors: Min Li (Bridgewater, NJ); Aixing Fan (Bridgewater, NJ); Nadia Soliman (East Brunswick, NJ); Komal Shahani (Edison, NJ); Junhong Mao (Plainsboro, NJ); Thomas Boyd (Metuchen, NJ); Amira Khan (East Windsor, NJ); Mavis Dennis (Sayreville, NJ); Stephy Qianwen Chung (Somerset, NJ)
Assignee: Colgate-Palmolive Company
A61K8/73A61K8/342A61K8/365A61Q19/007A61K2800/85
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,201,713
App. No.
17/901,710
Granted
Jan 21, 2025
Kind
B2
Abstract

Described herein are personal care compositions that may include from about 0.1 to about 5 wt. % of a polysaccharide; from about 0.01 to about 12 wt. % of a fatty alcohol; and from about 0.5 to about 7 wt. % of a post-biotic blend, wherein all weight percentages are based on the total weight of the personal care composition. Methods of making and using these personal care compositions are also described herein.

Claims (34)

1. A personal care composition comprising:

a polysaccharide comprising inulin present in an amount of from about 0.1 to about 1 wt. %;

from about 0.01 to about 12 wt. % of a fatty alcohol;

from about 0.5 to about 7 wt. % of a post-biotic blend; and

optionally, from about 0.1 to about 2 wt. % of ethylhexylglycerin,

wherein all weight percentages are based on the total weight of the personal care composition;

wherein the post-biotic blend comprises lactic acid, or a salt thereof; and pyruvic acid, or a salt thereof;

wherein the personal care composition has a weight ratio of lactic acid, or a salt thereof, to pyruvic acid, or a salt thereof, of from about 6:1 to about 2:1;

wherein the personal care composition is a body wash, a body lotion, a deodorant, or an antiperspirant.

2. The personal care composition according to claim 1 , wherein the polysaccharide further comprises cellulose, carboxymethyl hydroxyethylcellulose, cellulose acetate propionate carboxylate, hydroxyethylcellulose, hydroxyethyl ethylcellulose, hydroxypropylcellulose, hydroxypropyl methylcellulose, methyl hydroxyethylcellulose, microcrystalline cellulose, sodium cellulose sulfate, acacia, agar, algin, alginic acid, ammonium alginate, amylopectin, calcium alginate, calcium carrageenan, carnitine, carrageenan, dextrin, gelatin, gellan gum, guar gum, guar hydroxypropyltrimonium chloride, hectorite, hyaluronic acid, hydrated silica, hydroxypropyl chitosan, hydroxypropyl guar, karaya gum, kelp, locust bean gum, natto gum, potassium alginate, potassium carrageenan, propylene glycol alginate, sclerotium gum, sodium carboxymethyl dextran, carrageenan, tragacanth gum, xanthan gum, biosaccharide gum, or a combination of two or more thereof.

3. The personal care composition according to claim 1 , wherein the polysaccharide further comprises carrageenan, galacto-oligosaccharides, fructooligosaccharides, a-glucan oligosaccharide, beta glucan oligosaccharide or a combination thereof.

4. The personal care composition according to claim 1 , wherein the fatty alcohol comprises butyloctanol.

5. The personal care composition according to claim 1 , wherein the post-biotic blend further comprises at least one short chain fatty acid other than lactic acid and pyruvic acid or a salt thereof.

6. The personal care composition according to claim 5 , wherein the at least one short chain fatty acid is selected from pentanoic acid, CH 3 CH 2 CH 2 CH 2 COOH, isovaleric acid, 3-methylbutanoic acid, (CH 3 ) 2 CHCH 2 COOH, 2-methylpropanoic acid, (CH 3 ) 2 CHCOOH, butanoic acid, CH 3 CH 2 CH 2 COOH, CH 3 CH 2 COOH, ethanoic acid, CH 3 COOH, methanoic acid, HCOOH, acetic acid, butanedioic acid, succinic acid, formic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, a derivative thereof, a salt thereof, and a combination of two or more thereof.

7. The personal care composition according to claim 1 , wherein the post-biotic blend comprises lactic acid and a salt of pyruvic acid.

8. The personal care composition according to claim 1 , wherein the personal care composition has a weight ratio of lactic acid, or a salt thereof, to pyruvic acid, or a salt thereof, of about 4:1.

9. The personal care composition according to claim 1 , wherein the weight ratio of lactic acid, or a salt thereof, to pyruvic acid, or a salt thereof, is from about 5:1 to about 3:1.

10. The personal care composition according to claim 1 , wherein the post-biotic blend is a biomimetic postbiotic blend adapted to mimic lactobacillus ferment.

11. A personal care composition comprising:

a polysaccharide comprising inulin present in an amount of from about 0.1 to about 1 wt. %;

from about 2 to about 12 wt. % of a fatty alcohol;

from about 0.5 to about 10 wt. % of a fatty ester;

from about 0.5 to about 7 wt. % of a post-biotic blend; and

optionally, from about 0.1 to about 2 wt. % of ethylhexylglycerin,

wherein all weight percentages are based on the total weight of the personal care composition;

wherein the post-biotic blend comprises lactic acid, or a salt thereof; and pyruvic acid, or a salt thereof;

wherein the personal care composition has a weight ratio of lactic acid, or a salt thereof, to pyruvic acid, or a salt thereof, of from about 6:1 to about 2:1; and

wherein the personal care composition is a body wash, a body lotion, a deodorant, or an antiperspirant.

12. The personal care composition according to claim 11 , wherein the polysaccharide further comprises carrageenan.

13. The personal care composition according to claim 11 , wherein the fatty alcohol comprises cetearyl alcohol, cetyl alcohol, stearyl alcohol, butyloctanol, or a combination of two or more thereof.

14. The personal care composition according to claim 11 , wherein the fatty alcohol comprises butyloctanol and at least one of cetearyl alcohol, cetyl alcohol, and stearyl alcohol.

15. The personal care composition according to claim 11 , wherein the fatty alcohol comprises a mixture of butyloctanol, cetearyl alcohol, cetyl alcohol, and stearyl alcohol.

16. The personal care composition according to claim 11 , wherein the personal care composition is formulated to inhibit the growth of M. restricta by about 5% or more and increase the growth of S. epidermidis by about 5% or more by counting CFU/mL or reading optical density after incubating a 2 ml of a bacterial culture having an optical density of 0.8 and 0.38 at 610 nm using a UV-VIS Spectrometer for M. restricta and S. epidermidis , respectively, with a 2 ml of 1% personal care product at a temperature of 37° C. for 3 hours.

17. The personal care composition according to claim 11 , wherein the composition is formulated to inhibit the growth of M. restricta, C. striatum , and E. coli cumulatively by about 5% or more and increase the growth of S. epidermidis by about 5% or more by counting CFU/mL or reading optical density after incubating a 2 ml of a bacterial culture having a 0.1 optical density at 610 nm using a UV-VIS Spectrometer for M. restricta, C. striatum, E. coli , and S. epidermidis with a 2 ml of 1% personal care product at a temperature of 37° C. for 3 hours.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2022
From: LI, MIN; FAN, AIXING; SOLIMAN, NADIA; SHAHANI, KOMAL; MAO, JUNHONG; BOYD, THOMAS; KHAN, AMIRA; DENNIS, MAVIS; CHUNG, STEPHY QIANWEN
To: COLGATE-PALMOLIVE COMPANY
Reel/Frame 060989/0846 →
Continuity (2)
Provisional Application 63239624 · Sep 1, 2021
Related Publication 20230225955A1 · Jul 20, 2023
References Cited (129)
US 2350047A · Emil et al. · 1944 [cited by applicant]
US 5262153A · Mishima et al. · 1993 [cited by applicant]
US 5618522A · Deckner et al. · 1997 [cited by applicant]
US 5785962A · Hinz et al. · 1998 [cited by applicant]
US 6017548A · Epstein et al. · 2000 [cited by applicant]
US 6139850A · Hahn et al. · 2000 [cited by applicant]
US 6365137B1 · Aust et al. · 2002 [cited by applicant]
US 7250174B2 · Lee et al. · 2007 [cited by applicant]
US 8227426B2 · Gupta et al. · 2012 [cited by applicant]
US 8435955B2 · Masui et al. · 2013 [cited by applicant]
US 8673327B2 · Lemoine et al. · 2014 [cited by applicant]
US 8741357B2 · Lamy et al. · 2014 [cited by applicant]
US 8802065B2 · Oshimura et al. · 2014 [cited by applicant]
US 8933131B2 · Carter et al. · 2015 [cited by applicant]
US 8992898B2 · Klingman · 2015 [cited by applicant]
US 9566223B2 · Klingman · 2017 [cited by applicant]
US 9668948B2 · Klingman · 2017 [cited by applicant]
US 9713604B2 · Dreher · 2017 [cited by applicant]
US 10071103B2 · Sengupta et al. · 2018 [cited by applicant]
US 10406085B2 · Dubovoy et al. · 2019 [cited by applicant]
US 10532014B2 · Lesniak et al. · 2020 [cited by applicant]
US 10638755B2 · Pesaro et al. · 2020 [cited by applicant]
US 10864147B2 · Hilliard, Jr. et al. · 2020 [cited by applicant]
US 10933000B2 · Hilliard, Jr. et al. · 2021 [cited by applicant]
US 11104868B2 · Hardy et al. · 2021 [cited by applicant]
US 11331253B2 · Fan · 2022 [cited by applicant]
US 20030053970A1 · Bruening et al. · 2003 [cited by applicant]
US 20040076654A1 · Gamble · 2004 [cited by applicant]
US 20060182708A1 · Bockmuhl et al. · 2006 [cited by applicant]
US 20070167529A1 · Walton et al. · 2007 [cited by applicant]
US 20070243155A1 · Bottiglieri et al. · 2007 [cited by applicant]
US 20080187562A1 · Fan et al. · 2008 [cited by applicant]
US 20080206170A1 · Nivaggioli et al. · 2008 [cited by applicant]
US 20080299068A1 · Omura et al. · 2008 [cited by applicant]
US 20100189753A1 · Van Bavel et al. · 2010 [cited by applicant]
US 20120006348A1 · Grollier et al. · 2012 [cited by applicant]
US 20130059929A1 · Koehler et al. · 2013 [cited by applicant]
US 20140205555A1 · Gale et al. · 2014 [cited by applicant]
US 20150050227A1 · Liu et al. · 2015 [cited by applicant]
US 20150202136A1 · Lanzalaco et al. · 2015 [cited by applicant]
US 20160151257A1 · Klingman · 2016 [cited by applicant]
US 20170181950A1 · Wu · 2017 [cited by examiner]
US 20170183452A1 · Panandiker et al. · 2017 [cited by applicant]
US 20180177692A1 · Garcia et al. · 2018 [cited by applicant]
US 20190183780A1 · Pan et al. · 2019 [cited by applicant]
US 20190270951A1 · Hardy et al. · 2019 [cited by applicant]
US 20200016053A1 · Hilliard, Jr. et al. · 2020 [cited by applicant]
US 20200129405A1 · Mitchell · 2020 [cited by examiner]
US 20200405674A1 · Schiller et al. · 2020 [cited by applicant]
US 20210275418A1 · Bhardwaj · 2021 [cited by applicant]
US 20210275419A1 · Li et al. · 2021 [cited by applicant]
US 20210283025A1 · Das et al. · 2021 [cited by applicant]
US 20210299020A1 · Cruz et al. · 2021 [cited by applicant]
US 20220031591A1 · Botto et al. · 2022 [cited by applicant]
US 20220079854A1 · Li · 2022 [cited by applicant]
US 20220241162A1 · Fan et al. · 2022 [cited by applicant]
US 20220395437A1 · Leva · 2022 [cited by applicant]
CN 101107045 · 2008 [cited by applicant]
CN 101182299 · 2008 [cited by applicant]
CN 101820753 · 2010 [cited by applicant]
CN 103690380 · 2014 [cited by applicant]
CN 109259188 · 2019 [cited by applicant]
DE 19643585 · 1998 [cited by applicant]
DE 102004032734 · 2005 [cited by applicant]
EP 0345082 · 1989 [cited by applicant]
EP 0749749 · 1996 [cited by applicant]
EP 1443892 · 2004 [cited by applicant]
EP 1510200 · 2005 [cited by applicant]
EP 1526827 · 2005 [cited by applicant]
EP 2353579 · 2011 [cited by applicant]
EP 2374835 · 2011 [cited by applicant]
JP H09110650 · 1997 [cited by applicant]
JP 2004089177 · 2004 [cited by applicant]
KR 20120070104 · 2012 [cited by applicant]
KR 101189187 · 2012 [cited by applicant]
KR 20140039548 · 2014 [cited by applicant]
KR 20150011060 · 2015 [cited by applicant]
KR 101503979 · 2015 [cited by applicant]
KR 101768921 · 2017 [cited by applicant]
WO 2009020582 · 2009 [cited by applicant]
WO 2009046008 · 2009 [cited by applicant]
WO 2010044076 · 2010 [cited by applicant]
WO 2011099849 · 2011 [cited by applicant]
WO 2017030560 · 2017 [cited by applicant]
WO 2018022016 · 2018 [cited by applicant]
WO 2019117858 · 2019 [cited by applicant]
WO 2020052916 · 2020 [cited by applicant]
WO 2020057761 · 2020 [cited by applicant]
WO 2020185654 · 2020 [cited by applicant]
WO 2021096518 · 2021 [cited by applicant]
WO 2021183462 · 2021 [cited by applicant]
WO 2021183464 · 2021 [cited by applicant]
WO 2022063857 · 2022 [cited by applicant]
Evans et al., 2012, “Axillary skin biology and care”, International Journal of Cosmetic Science, 34:389-395. [cited by applicant]
IFSCC, 1998, Antiperspirants-and-Deodorants: Principles of Underarm Technology, Micelle press IFSCC No. 6, pp. 1-61. [cited by applicant]
International Search Report and the Written Opinion of the International Searching Authority issued in International Application PCT/US2022/042563 mailed Jan. 20, 2023. [cited by applicant]
Johnson, 2022, “How to Best Treat Acne Scars,” Medical News Today (online website: [(https://www.medicalnewstoday.com/articles/324784, pp. 1-14)]. [cited by applicant]
Laboratoire SVR, 2017, “48H Anti-Perspirant Deodorant Roll-on”, Mintel Database GNPD AN: 5111953. [cited by applicant]
Anonymous, “Ingredients of Filorga Ultimate Revitalizing Night Cream,” retrieved from https://www.cosdna.com/chs/cosmetic_4251189624.html, published on May 16, 2015. [cited by applicant]
Anonymous, 2021, “Atopicare Shower Cream”, Mintel Database GNPD AN: 8747223. [cited by applicant]
International Search Report and the Written Opinion of the International Searching Authority issued in International Application PCT/US2022/042327 mailed Dec. 20, 2022. [cited by applicant]
Allies Group, 2017, “Promise Keeper Blemish Facial”, Mintel Database GNPD AN: 5196555. [cited by applicant]
Anonymous, 2005, “Intensity Classic Deo Roll-On”, Mintel Database GNPD AN: 371579. [cited by applicant]
Anonymous, 2006, “Micro Exfoliating Oxygenating Gel”, Mintel Database GNPD AN: 598917. [cited by applicant]
Anonymous, 2011, “E.V.E. Essential Vital Elements Serum Source”, Mintel Database GNPD AN: 1666406. [cited by applicant]
Anonymous, 2011, “Milk Body Lotion”, Mintel Database GNPD AN: 1632704. [cited by applicant]
Anonymous, 2012, “Super-Mud Clearing Treatment”, Mintel Database GNPD AN: 1921209. [cited by applicant]
Anonymous, 2014, “Clinical Concentrate Radiance Booster”, Mintel Database GNPD AN: 2350479. [cited by applicant]
Anonymous, 2014, “Intimate Wash”, Mintel Database GNPD AN: 2677521. [cited by applicant]
Anonymous, 2017, “Acne on The Spot Serum”, Mintel Database GNPD AN: 4688909. [cited by applicant]
Anonymous, 2018, “Shaveless Hair Minimizing Anti-Perspirant Deodorant Roll-On”, Mintel Database GNPD AN: 5574907. [cited by applicant]
Anonymous, 2019, “Superserum 6-Acid Refining Treatment”, Mintel Database GNPD AN: 6521601. [cited by applicant]
Anonymous, 2019, “Supertoner Exfoliating Acid Soution”, Mintel Database GNPD AN: 6457009. [cited by applicant]
Boyd (https://www.chemservice.com/news/2014/08/which-chemicals-make-deodorants-and-antiperspirants-work/), Aug. 22, 2014, pp. 1-2 (Year:2014). [cited by applicant]
International Search Report and the Written Opinion of the International Searching Authority issued in International Application PCT/US2019/061522 mailed May 12, 2020. [cited by applicant]
International Search Report and the Written Opinion of the International Searching Authority issued in International Application PCT/US2020/021657 mailed May 27, 2020. [cited by applicant]
International Search Report and the Written Opinion of the International Searching Authority issued in International Application PCT/US2021/021426 mailed Jun. 28, 2021. [cited by applicant]
International Search Report and the Written Opinion of the International Searching Authority issued in International Application PCT/US2021/021428 mailed Jun. 28, 2021. [cited by applicant]
Cosinter, 2011, “Intimate Liquid Soap”, Mintel Database GNPD AN: 1547745. [cited by applicant]
Do Couto et al., 2016, “Antifungal Activity of the Piroctone Olamine in Intra-Abdominal Candidiasis”, Spinger Plus, 5:468. [cited by applicant]
IFSCC Monograph, No. 6, “Antiperspirants-and-Deodorants: Principles of Underarm Technology,” Micelle Press, 76 pages, 1998. [cited by applicant]
International Search Report and the Written Opinion of the International Searching Authority issued in International Application PCT/US2023/031519 mailed Nov. 30, 2023. [cited by applicant]
International Search Report and the Written Opinion of the International Searching Authority issued in International Application PCT/US2023/031632 mailed Nov. 30, 2023. [cited by applicant]
Pharma Solutions, 2022, “Cleansing Bar”, Mintel Database GNPD AN: 9713532. [cited by applicant]
Cork, 1996, “The role of [cited by applicant]
Patel, 2014, “Postinflammatory hyperpigmentation: Review of pathogenesis, prevention, and treatment”, Pigment International, vol. 1, Issue 2, pp. 59-69. [cited by applicant]
Celltrion Skincure, 2021, “Cleansing Oil & Blackhead”, Mintel Database GNPD AN: 8549187. [cited by applicant]
Coreana Cosmetics, 2020, “Peeling Pad”, Mintel Database GNPD AN: 7440987. [cited by applicant]
International Search Report and the Written Opinion of the International Searching Authority issued in International Application PCT/US2023/084725 mailed Mar. 28, 2024. [cited by applicant]